Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LIPOCINE INC.

(LPCN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
CommuniquÚs de presse de la sociÚtÚ LIPOCINE INC.
04:03pLIPOCINE INC. : Change in Directors or Principal Officers (form 8-K)
AQ
01/14LIPOCINE INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stan..
AQ
01/05Lipocine to Present Clinical Data on LPCN 1144 at 2022 NASH-TAG Conference
PR
01/04LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : ANNOUNCES patient dosed in its Phase 2 Study with LPCN 1148 for management of l..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Lipocine announces patient dosed in its phase 2 study with lpcn 1148 for management of ..
PR
2021LIPOCINE : Q3 Earnings Snapshot
AQ
2021Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 - F..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021Lipocine Announces FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Entry into a Material Definitive Agreement, Material Modification to Right..
AQ
2021Lipocine Announces Multiple Poster Presentations At The American Association For The St..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021ANTARES PHARMA : Enters into exclusive license agreement with lipocine for tlando in u.s.
AQ
2021LIPOCINE : And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO
AQ
2021LIPOCINE : AND ANTARES PHARMA ENTER INTO U.S. Licensing Agreement to Commercialize TLANDO«..
PU
2021LIPOCINE INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fina..
AQ
2021LIPOCINE : And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO«
PR
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : to Present at The H.C. Wainwright 5th Annual NASH Investor Conference
PR
2021LIPOCINE : Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO
AQ
2021LIPOCINE : ANNOUNCES FDA AFFIRMATION of class 1 NDA RESUBMISSION FOR TLANDO« (Form 8-K)
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO«
PR
2021LIPOCINE : to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference
PR
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : to Present at The H.C. Wainwright 23rd Annual Global Investment Conference
PR
2021LIPOCINE : 1144 Presentation-LiFT Topline 36 Week Results
PU
2021LIPOCINE : Both LPCN 1144 treatment arms met with statistical significance the pre-specifi..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endp..
PR
2021LIPOCINE : Q2 Earnings Snapshot
AQ
2021LIPOCINE : Announces Financial Results for the Second Quarter Ended June 30, 2021
PR
2021LIPOCINE : Announces Settlement With Clarus Therapeutics (Form 8-K)
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : Announces Settlement With Clarus Therapeutics
PR
2021LIPOCINE : To Present At The Ladenburg Thalmann Healthcare Conference
PR
2021LIPOCINE : Announces Presentations at the International Liver Congress 2021 Digital Event
AQ
2021LIPOCINE : Announces Presentations at The International Liver Congress™ 2021 Digital..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : Announces Presentations at The International Liver Congress™ 2021 Digital..
PR
2021LIPOCINE : To Present At The Raymond James Human Health Innovation Conference
PR
2021LIPOCINE : FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study ..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
PR
2021LIPOCINE INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2021ABSTRACT TITLED “ORAL LPCN 114 : Results of a Phase 2 Randomized Controlled Study&rd..
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : to Present at the Lytham Partners Summer 2021 Investor Conference
PR
2021LIPOCINE : Summary Judgment RULING in Patent Infringement Lawsuit (Form 8-K)
PU
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : Summary Judgment Ruling in Patent Infringement Lawsuit
PR
2021CLARUS THERAPEUTICS : Defeats Lipocine's Patent Infringement Lawsuit On Summary Judgment
PR
2021LIPOCINE : Q1 Earnings Snapshot
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : This annual report on form 10-k, in particular "item 7. management's discussion..
AQ
2021LIPOCINE : Announces Presentations on TLANDO at ENDO 2021 Conference
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE : to Present at Two Upcoming Investor Conferences
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial..
AQ
2021LIPOCINE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statem..
AQ
2021LIPOCINE INC. : Results of Operations and Financial Condition, Other Events (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2021LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
1  2  3  4Next
Upcoming event on LIPOCINE INC.